Quantifying CKD-aP: Tools for Better Care
James Burton, DM, FRCP
Emilio Sanchez, MD, PhD
Decoding Itch in CKD: From CKD-aP Suspicion to Solution
Leonie Kraft, MD
Lucio Manenti, MD, PhD
CKD-aP Treatment Tool Kit
The Patient-Clinician Connection in Managing CKD-aP
Real-World IgAN: A Case-Based Approach to Maximizing Kidney Preservation
An De Vriese, MD, PhD
Muh Geot Wong, MBBS, PhD
Optimizing RAASi/MRA Therapy in Patients with Heart Failure, CKD, and Hyperkalemia: A Microlearning Curriculum Approach
Javed Butler, MD
Ellie Kelepouris, MD, FACP, FAHA
Patrick Rossignol, MD, PhD
The Critical Interplay: CKD, HF, and HyperkaleAmia
FSGS: When Solutions Fall Short
Meghan Sise, MD
FSGS: Interpretation of Proteinuria Reduction Thresholds
Vladimir Tesar
FSGS 360°: From Patient Experience to Precision Medicine
Kenneth Lieberman, MD
Emerging Therapies in Managing Adult and Pediatric Patients With FSGS: Latest Data
Integrating the Patient Voice in FSGS Management
Monitoring FSGS: Traditional and Novel Biomarkers
The Clinical Weight of TTR: What the Latest Data Reveal
Ahmad Masri, MD, MS
Rola Khedraki, MD, FACC
Optimizing IgAN Care: Achieving Lower Proteinuria Targets With Combination Therapy
Jonathan Barratt, MD, PhD
Sydney Tang, MBBS, MD
Differentiating Neuromodulation Therapies: VNS, DBS, ECT, TMS
Raman Sankar, MD, PhD
Scott Aaronson, MD